Online market intelligence platform
No value published
The submission route named on the official notice.
Medicines Discovery Catapult has published 125 notices across all categories, and 22% of its awards go to a supplier it has used before.
Which is the argument for getting on the list rather than winning this one. The incumbent is rarely the last winner — it is the roster. See the retention odds by category →
Access to a platform which identifies and researches companies within our target sector - biopharma, biotech, diagnostics and med-tech
Make the case to bid
Reveal who to approach at Medicines Discovery Catapult, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
The full intelligence dossier
Our agent reads Medicines Discovery Catapult’s accounts, hunts live signals, finds the people who decide — and hands you a bid strategy plus a go-to-market influence plan, including what your team should post this week. You approve every paid step.
Five included while we’re in beta, and the agent asks before it spends on any paid step.
- OCID
- ocds-h6vhtk-02e35b
- Stage
- tender · Open
- Source
- Find a Tender
- Buyer ref
- 023528-2021
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Research & Development
Medicines Discovery Catapult’s tender network